4//SEC Filing
HOROWITZ ZEBULUN D 4
Accession 0000950117-09-000230
CIK 0000722104other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 5:24 PM ET
Size
7.7 KB
Accession
0000950117-09-000230
Insider Transaction Report
Form 4
HOROWITZ ZEBULUN D
SVP - Chief Medical Officer
Transactions
- Sale
Common Stock, $.01 par value per share
2009-02-17$5.87/sh−5,380$31,555→ 144,683 total - Exercise/Conversion
Option to Purchase Common Stock, $.01 par value
2009-02-19$5.27/sh−50,000$263,500→ 50,000 totalExercise: $5.27From: 2010-02-19Exp: 2019-02-19→ Common Stock, $.01 par value per share (50,000 underlying)
Footnotes (2)
- [F1]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934, to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 15, 2007.
- [F2]These options will become exercisable as to 25% on each of 2/19/10, 2/19/11, 2/19/12 and 2/19/13, provided the optionee remains employed by the Company on these dates.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001225436
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 5:24 PM ET
- Size
- 7.7 KB